Elekta, Inc. Recalls Leksell GammaPlan Software Due to Potential Incorrect Patient Irradiation Risk
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Elekta, Inc. has issued a voluntary recall for Leksell GammaPlan software versions 11.3 and 11.4 due to a software error that may result in radiation treatment at the wrong patient location.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Elekta, Inc. has initiated a voluntary Class II recall of its Leksell GammaPlan software. The recall was triggered by a software error that occurs when defining a new stereotactic reference. If a user fails to first change an already defined obsolete reference to a pre-plan reference, the system may generate a treatment plan that potentially irradiates the incorrect patient location. This risk exists if the error is not detected by medical staff during the planning process.
Which Products Are Affected
The recall affects the Leksell GammaPlan Radionuclide RT Treatment planning system, specifically software versions 11.3 and 11.4.
- Product Name: Leksell GammaPlan
- Recall Number: Z-1340-2026
- Lot Codes: 07340048311878 (Version 11.3) and 07340201502136 (Version 11.4)
The product was distributed worldwide. In the United States, distribution included nationwide coverage with specific records for AK, AZ, CA, CO, ST, FL, GA, HI, IA, IL, LA, MA, MI, MN, MO, NC, NJ, NM, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, and WV. International distribution reached over 45 countries, including Canada, China, France, Germany, Japan, and the United Kingdom.
What You Should Do
Elekta, Inc. initiated the recall on December 12, 2025, via a notification letter to affected customers. Medical facilities and practitioners using Leksell GammaPlan versions 11.3 or 11.4 should be vigilant when defining stereotactic references. Users must ensure that any obsolete references are manually changed to pre-plan references as required by the software workflow to prevent targeting errors. For additional information or technical support, facilities can contact Elekta, Inc. at their Atlanta headquarters located at 400 Perimeter Center Ter NE Ste 50, Atlanta, GA 30346-1227.
Why This Matters
This software error poses a high safety risk because incorrect radiation targeting can lead to the irradiation of healthy tissue or unintended anatomical sites, which may cause serious medical complications or injury to the patient.
Source
Information provided by the FDA. Recall Event ID: 98212.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.